[16].          Antibacterial Surfaces Prepared through Electropolymerization of N-Heterocyclic Carbene Complexes: A Pivotal Role of the Metal.
Q. Gaudillat, H. Ben Halima, A. Figarol, V. Humblot, I. Jourdain, B. Lakard, J. Bausells, and L. Viau

ACS Applied Bio Materials, 8:3, 2025. 
 

[15].        Coordination assemblies of acetylenic dithioether ligands on silver(I) salts: crystal structure, antibacterial and cytotoxicity activities.
Q. Gaudillat, J.L. Kirchhoff, I. Jourdain, V. Humblot, A. Figarol, M. Knorr, C. Strohmann, and L. Viau

Inorganic chemistry, 63:41, 2024. 

[14].        A kinetic approach to synergize bactericidal efficacy and biocompatibility in silver-based sol–gel coatings.
T. Zwingelstein, A. Figarol, V. Luzet, M. Crenna, X. Bulliard, A. Finelli, J. Gay, X. Lefèvre, R. Pugin, J-F. Laithier, F. Chérioux, and V. Humblot

 ACS Omega, 9:23, 2024. 

[13].        A coculture based, 3D bioprinted ovarian tumor model combining cancer cells and cancer associated fibroblasts.
Z. Baka, C. Godier,  L. Lamy,  A. Mallick, V. Gribova, A. Figarol,  L. Bezdetnaya, A. Chateau, Z. Magne, M. Stiefel, D. Louaguef, P. Lavalle, E. Gaffet, O. Joubert, and H. Alem.

MacroMolecular Bioscience,  23:3, 2023. 

[12].        Cancer-on-chip technology: current applications in major cancer types, challenges and future prospects.
Z. Baka, M. Stiefel, A. Figarol, C. Godier, A. Mallick, O. Joubert, N. Ashammakhi, E. Gaffet, and H. Alem.

Progress in Biomedical Engineering,  4:032001, 2022.

[11].         Biological Effects and Applications of Bulk and Surface Acoustic Waves on In Vitro Cultured Mammal Cells: New Insights.
A. Figarol,  L. Olive, O. Joubert, L. Ferrari, B. H. Rihn, F. Sarry, and D. Beyssen.

Biomedicines,  10:5, 2022.

[10].        Three-Dimensional in vitro Models of Healthy and Tumor Brain Microvasculature for Drug and Toxicity Screening.
M. Piantino,  A. Figarol, and M. Matsusaki.
Frontiers in toxicology, 3:656254, 2021.

[9].       Interstitial flow regulates in vitro three-dimensional self-organized brain micro-vessels.
A. Figarol, M. Piantino,  T. Furihata,  T. Satoh, S. Sugiura, T. Kanamori and M. Matsusaki.
Biochemical and Biophysical Research Communications, 553:3, 2020.

[8].      An in vitro self-organized three-dimensional model of the blood-brain barrier microvasculature.
A. Figarol, Y. Naka, Y. Shigemoto-Mogami, T. Furihata, K. Sato and M. Matsusaki.
Biomedical materials, 16:1, 2020.

[7].      Quantitative Flow Cytometric Evaluation of Oxidative Stress and Mitochondrial Impairment in RAW 264.7 Macrophages after Exposure to Pristine, Acid Functionalized, or Annealed Carbon Nanotubes.
O. Sabido, A. Figarol, J-P. Klein, V. Bin, V. Forest, J. Pourchez, B. Fubini, M. Cottier, M. Tomatis, and D. Boudard.
Nanomaterials, 10:2, 2020.

[6].     A journey from the endothelium to the tumor tissue: distinct behavior between PEO-PCL micelles and polymersomes nanocarriers.
A. Figarol, L. Gibot, M. Golzio, B. Lonetti, A-F. Mingotaud, and M-P. Rols.
Drug Delivery, 25:1, 2018.

[5].     Transport of nano-objects in narrow channels: influence of Brownian diffusion, confinement and particle nature.
 O. Liot, M. Socol, L. Garcia, J. Thiéry, A. Figarol, A-F. Mingotaud, and P. Joseph.
Journal of Physics: Condensed Matter, 30:23, 2018.

[4].     Adsorption of lactate dehydrogenase enzyme on carbon nanotubes: how to get accurate results about the cytotoxicity of these nanomaterials.
V. Forest , A. Figarol, D. Boudard, M. Cottier, P. Grosseau, and J. Pourchez.
Langmuir, 31:12, 2015.

[3].     Thermal annealing of carbon nanotubes reveals a toxicological impact of the structural defects.
A. Figarol, J. Pourchez, D. Boudard, V. Forest , S. Berhanu, J-M. Tulliani, J-P. Lecompte, M. Cottier, D. Bernache-Assollant, and P. Grosseau.
Journal of Nanoparticles Research, 17:4, 2015.

[2].     In vitro toxicity of carbon nanotubes, nano-graphite and carbon black, similar impacts of acid functionalization.
A. Figarol, J. Pourchez, D. Boudard, V. Forest , C. Akono, J-M. Tulliani, J-P. Lecompte, M. Cottier, D. Bernache-Assollant, and P. Grosseau.
Toxicology in vitro, 30:1, 2015.

[1].     Biological response to purification and acid functionalization of carbon nanotubes.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J-M. Tulliani, J-P. Lecompte, M. Cottier, D. Bernache-Assollant, and P. Grosseau. 
Journal of Nanoparticles Research, 16:2507, 2014.

[1].      Modèles 3D de micro-vaisseaux cérébraux et applications pour des tumeurs-sur-puces : défis et intérêts des techniques d’histologie.
A. Figarol, R. Mosbah, M. Pouit, S. Chamouton, M. Matsusaki, A. Yamada, T. Furihata, F. Chollet, T. Leblois, and V. Humblot.
Revue française d'histotechnologie, 36:1, 2024

[1].      Cerebrovascular model and device.
M. Matsusaki, and A. Figarol, Osaka University, National Institute of Health Science.
WO2020196678A1.

[1].      Chapter 16: Blood-brain barrier tissue engineering.
A. Figarol, and M. Matsusaki.
In Biomaterials for organ and tissue regeneration: new technologies and future prospects, edited by N.E. Vrana, H. Knopf-Marques, and J. Barthes, ISBN: 978-0-08-102907-7, Elsevier, Cambridge, UK, 30 March 2020.

In vitro toxicity and physico-chemical properties of carbon nanotubes, 2014.   Manuscript

Oral communications in peer-reviewed international conferences

[6].     Blood-brain barrier capillary self-organization for a 3D scaffold-free adaptable in vitro model.
A. Figarol, Y. Naka, Y. Shigemoto-Mogami, T. Furihata, K. Sato, and M. Matsusaki.
Biomedical Engineering Society (BMES), Annual Meeting, Philadelphia, USA, 2019.

[5].      In vitro Tridimensional Model of the Blood-Brain Barrier by Capillary Self-Organization.
A. Figarol, Y. Naka, and M. Matsusaki.
Rapid fire presentation, Society for Biomaterials (SFB), Seattle, USA, 2019.  Abstract.

[4].      Development of an in vitro model to predict the passage of polymersomes nanovectors through the endothelial barrier for an optimized drug delivery to tumor cells.
A. Figarol, A.F. Mingotaud, M.P. Rols, and L. Gibot.
Nanomedicine and drug delivery, Osaka, Japan, 2017. Abstract.

[3].     In vitro toxicity of carbon nanotubes, nano-graphite and carbon black: similar impacts of acid functionalization
J. Pourchez, A. Figarol, D. Boudard, V. Forest, C. Akono, J.M. Tulliani, J.P. Lecompte, M. Cottier, D. Bernache-Assolant, and P. Grosseau.
Nanoworld conference, Boston, USA, 2017. 

[2].      Biological response to purification and acid functionalization of carbon nanotubes.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J.M. Tulliani, J.P. Lecompte, D. Bernache-Assollant, M. Cottier, and P. Grosseau.
International Conference on Safe production and use of nanomaterials, Nanosafe, Grenoble, France, 2014.

[1].      Control of carbon nanotubes biological activity by acid functionalization: a Janus impact on in vitro cellular response.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J.M. Tulliani, J.P. Lecompte, M. Cottier, D. Bernache-Assollant, and P. Grosseau.
Nanosmat USA, Houston, USA, 2014.

Oral communications in seminars and national congress

 [12].         A hydrogel to enable the 3D self-organization of a brain micro-vasculature.
A. Figarol, M. Gourgues, A.Yamada, T. Furihata, T. Leblois, F. Chollet, V. Humblot, M. Matsusaki
12ème journée thématique GDR CNRS 3751 B2i, Focus sur l'ingénierie tissulaire, Paris, France, 2024. 

[11].        Development of a physiological microsystem, from a blood-brain barrier-on-chip to a vascularized glioblastoma-on-chip.
A. Figarol. (invited),  R. Mosbah, M. Matsusaki, A. Yamada, T. Furihata, F. Chollet, T. Leblois, V. Humblot
19th annual meeting Cancéropole Grand Sud Ouest, Arcachon, France, 2023. 

[10].        Development of vascularized tumor-on-chips: toward a physiological microsystem modeling the glioblastoma and blood-brain barrier.
A. Figarol. (invited)
13ème forum du Cancéropole Est, Strasbourg, France, 2023. 

[9].       3D models of brain micro-vessels and applications for tumor-in-chips.
A. Figarol. (invited)
36ème congrès de l'AFH, Dijon, France, 2023. 

[8].      From nano-biointeractions to tissue engineering.
A. Figarol.
Pepite scientific seminar, Besançon, France, 2022.

[7].      In Vitro Blood Brain Barrier (BBB) Models by Capillary Self organization System.
A. Figarol, M. Matsusaki.
JSPS-NRF Joint Symposium, Osaka, Japan, 2019.

[6].      Construction of cerebrovascular network by tissue engineering using micro-sized scaffold and application to permeability test.
Y. Naka, A. Figarol,Y. Shigemoto-Mogami, K. Sato, and M. Matsuzaki.
41st Japan Biomaterials Conference, Tsukuba, Japon, 2019. 

[5].      Development of a brain blood barrier model,
A. Figarol, M. Matsusaki.
Alternatives to animal testing. Joint seminar with Wageningen University, Osaka, Japan, 2018.

[4].      Nanobiointeractions, from physico-chemical characteristics to cellular response.
A. Figarol. 
Seminar in Osaka University, School of engineering, Osaka, Japan, 2017.

[3].      Understanding the interaction of polymersome nanovectors with the endothelial barrier and tumor cells for an optimized drug delivery.
A. Figarol, A.F. Mingotaud, M.P. Rols, and L. Gibot. 
Young Researchers Workshop, “Nanomedicine in Cancer”, Cancéropole GSO, Montauban, France, 2017.

[2].      Development of an in vitro model to predict the passage of polymersomes nanovectors through the endothelial barrier for an optimized drug delivery to tumor cells.
A. Figarol, A.F. Mingotaud, M.P. Rols, and L. Gibot.
Journées du Groupe Français des Polymères du Sud-Ouest, Latresne, France, 2017.

[1].      Polymeric self-assemblies for nanomedicine: a critical approach.
U. Till, A. Figarol, M. Demazeau, C. Magnani, B. Lonetti, J.-D. Marty,  A.-F. Mingotaud, C. Mingotaud, C. Roux, P. Vicendo, and N. De Viguerie.
Journées Montoulouse, Montpellier, France, 2017. 

Posters in peer-reviewed international conferences

[7].      A vascularized glioblastoma multiforme within a 3D perfused microphysiological system: combining a self-organized microvasculature and a central venule in a hydrogel. 

A. Figarol, R. Mosbah, M. Hamidullah, L. Durand, M. Pouit, S. Chamouton, F. Chollet, T. Leblois, and V. Humblot.
MPS World Summit 2023, Berlin, Germany, 2023.

[6].      Organ on Chip Platform with an Integrated Acoustic Biosensor and Polished Silicon Porous Membrane. 

 M. Hamidullah, A. Figarol, C. Elie-Caille, T. Leblois.
EUROOCS annual conference, Grenoble, France, 2022 

[5].      In vitro tridimensional model of the blood-brain barrier by capillary self-organization.
A. Figarol, Y. Naka, and M. Matsusaki.
Society for Biomaterials, Seattle, USA, 2019.

[4].      3D in vitro blood capillaries, towards a model of the blood brain barrier.
A. Figarol, D. Hikimoto, and M. Matsusaki.
Termis World Congress, Kyoto, Japan, 2018.

[3].      Polymeric self-assemblies for photodynamic therapy: a critical approach.
U. Till, L. Gibot, A.  Figarol,  B. Moukarzel, A.F. Mingotaud, C. Mingotaud, P. Vicendo, M.P. Rols, M. Gaucherand F. Violleau.
Nanomedicine and drug delivery, Osaka, Japan, 2017.

[2].      Assembly of Double-Hydrophilic Block Copolymers triggered by Gadolinium Ions: New Colloidal MRI Contrast Agents.
C. Frangville, Y. Li, C. Billotey, D.R. Talham, A. Figarol, L. Marmuse, P. Roux, J.-D. Marty and C. Mingotaud.
Nanomedicine and drug delivery, Osaka, Japan, 2017.

[1].      In vitro toxicity of carbon nanotubes: impact of acid functionalization.
A. Figarol, J. Pourchez, D. Boudard, D. Bernache-Assollant, M. Cottier, and P. Grosseau.
International Conference on Safe production and use of nanomaterials, Nanosafe, Grenoble, France, 2012.

Posters in seminars and national congress

[11].      Development of an instrumented physiological microdevice to study the impact of the vascular microarchitecture and tumoral context on the brain angiogenesis and blood brain barrier.
T. Sivier, M. Gourgues, L. Durand, F. Chollet, V. Humblot, T. Leblois, A. Figarol 

7th plenary days of the GDR B2i CNRS 3751,  Mulhouse, France, 2024.

[9] et [10].      Development of an instrumented physiological microdevice for the modelisation of human brain vasculature in tumoral context.
M. Gourgues, R. Mosbah, M. Pouit, T. Sivier, A. Figarol, V. Humblot
12ème journée thématique GDR CNRS 3751 B2i, Focus sur l'ingénierie tissulaire, Paris, France, 2024.
7th plenary days of the GDR B2i CNRS 3751,  Mulhouse, France, 2024. 

[8].      BioInterfaces aNd Devices team - the 3D-Glimpse project.
 A. Figarol, V. Humblot, T. Leblois

Les rencontres du GDR organoïdes, Paris, France, 2022.

[7].      Attempts to establish the in vitro BBB model suitable for drug development - Comparative study of 2D rat model, 2D human cell line model, and 3D human cell line model -.
K. Kitamura, Y. Shigemoto-Mogami, K. Hoshikawa, A. Figarol, M. Matsusaki, and T. Furihata.  Chem-Bio Informatics Society, Tokyo, Japan, 2019.

[6].      Towards a 3D in vitro model of the blood brain barrier.
A. Figarol, and M. Matsusaki.
Symposium on new technology for cell-based assay, Tsukuba, Japan, 2018.

[5].      Activité biologique de nanotubes de carbone : fonctionnalisation acide.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J-M. Tulliani, J-P. Lecompte, B. Pateyron, M. Cottier, D. Bernache-Assollant, and P. Grosseau. 
Journées NanoMicroTechnologies au service de la santé, St-Etienne, France, 2014.

[4].      Nanotubes de carbone fonctionnalisés : caractérisation physico-chimique et toxicité pulmonaire.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J-M. Tulliani, J-P. Lecompte, B. Pateyron, D. Bernache-Assollant, M. Cottier, and P. Grosseau. 
Matériaux, Montpellier, France, 2014, Poudre et Matériaux Frittés, Belfort-Montbéliard, France, 2013. 

[3].        Activité biologique de nanotubes de carbone : effet Janus de la fonctionnalisation acide.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J-M. Tulliani, J-P. Lecompte, B. Pateyron, D. Bernache-Assollant, M. Cottier, and P. Grosseau. 
Journée annuelle de l’IFRESIS, St-Etienne, France, 2013.

[2].        Nanotubes de carbone fonctionnalisés : caractérisation physico-chimique et toxicité in vitro.
A. Figarol, J. Pourchez, D. Boudard, V. Forest, J-M. Tulliani, J-P. Lecompte, B. Pateyron, D. Bernache-Assollant, M. Cottier, and P. Grosseau.
Journée  de la recherche de l’Ecole Doctorale ED SIS 488, St-Etienne, France, 2013.

[1].        Toxicité in vitro de nanotubes de carbone : impact de la fonctionnalisation acide. 

A. Figarol, J. Pourchez, D. Boudard, V. Forest, D. Bernache-Assollant, M. Cottier, and P. Grosseau. 
Journée annuelle de l’IFRESIS, St-Etienne, France, 2013.